Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing

被引:0
作者
Nina Frey
Luigi Tortola
David Egli
Sharan Janjuha
Tanja Rothgangl
Kim Fabiano Marquart
Franziska Ampenberger
Manfred Kopf
Gerald Schwank
机构
[1] Institute of Molecular Health Sciences,Institute of Pharmacology and Toxicology
[2] ETH Zurich,undefined
[3] University of Zurich,undefined
来源
Nature Communications | / 13卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Pancreatic ductal adenocarcinoma (PDA) is an inherently immune cell deprived tumor, characterized by desmoplastic stroma and suppressive immune cells. Here we systematically dissect PDA intrinsic mechanisms of immune evasion by in vitro and in vivo CRISPR screening, and identify Vps4b and Rnf31 as essential factors required for escaping CD8+ T cell killing. For Vps4b we find that inactivation impairs autophagy, resulting in increased accumulation of CD8+ T cell-derived granzyme B and subsequent tumor cell lysis. For Rnf31 we demonstrate that it protects tumor cells from TNF-mediated caspase 8 cleavage and subsequent apoptosis induction, a mechanism that is conserved in human PDA organoids. Orthotopic transplantation of Vps4b- or Rnf31 deficient pancreatic tumors into immune competent mice, moreover, reveals increased CD8+ T cell infiltration and effector function, and markedly reduced tumor growth. Our work uncovers vulnerabilities in PDA that might be exploited to render these tumors more susceptible to the immune system.
引用
收藏
相关论文
共 52 条
[1]  
Zhang Y(2020)Regulatory T cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis. Cancer Discov. 10 422-439
[2]  
Royal RE(2010)Phase 2 trial of single agent ipilimumab (Anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma J. Immunother. 33 828-833
[3]  
Steele NG(2020)Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer Nat. Cancer 377 2500-2501
[4]  
Carpenter ES(2017)Tumor mutational burden and response rate to PD-1 inhibition N. Engl. J. Med. 214 895-904
[5]  
Kemp SB(2017)PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity J. Exp. Med. 80 3070-3071
[6]  
Sirihorachai VR(2020)Targeting the microenvironment to overcome gemcitabine resistance in pancreatic cancer Cancer Res. 37 289-307.e9
[7]  
Yarchoan M(2020)Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer Cancer Cell 586 1-7
[8]  
Hopkins A(2020)Functional genomic landscape of cancer-intrinsic evasion of killing by T cells Nature 5 9561-418
[9]  
Jaffee EM(2020)Autophagy protects tumors from T cell-mediated cytotoxicity via inhibition of TNFa-induced apoptosis Sci. Immunol. 547 413-775
[10]  
Juneja VR(2017)In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target Nature 359 770-542